<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Rasch Raun | Activity</title>
	<link>https://recash.wpsoul.net/members/botanykarate4/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/botanykarate4/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Rasch Raun.</description>
	<lastBuildDate>Tue, 19 May 2026 17:26:43 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">0041f2ee43b0ecc991178f63867d4a66</guid>
				<title>Rasch Raun posted an update: LipomiR185i could accumulate in the liver and remain for at [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/57691/</link>
				<pubDate>Thu, 12 Dec 2024 08:08:14 +0000</pubDate>

									<content:encoded><![CDATA[<p>LipomiR185i could accumulate in the liver and remain for at least two weeks. <a href="https://www.selleckchem.com/products/jph203.html" rel="nofollow ugc">Nanvuranlat in vitro</a> More importantly, LipomiR185i significantly down-regulated the hepatic endogenous miR185 level in vitro and in vivo without significant tissue damage at 14 mg⋅kg-1. The construction of LipomiR185i provides a potential anti-atherosclerotic nanodrug a&hellip;<span class="activity-read-more" id="activity-read-more-57691"><a href="https://recash.wpsoul.net/activity/p/57691/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9d42ef41f014295309df28e86f3a703d</guid>
				<title>Rasch Raun posted an update: analysis was shown to be limited but not negligible. [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/53029/</link>
				<pubDate>Wed, 11 Dec 2024 17:30:12 +0000</pubDate>

									<content:encoded><![CDATA[<p>analysis was shown to be limited but not negligible.</p>
<p> Classical low-flow, low-gradient (LF/LG) aortic stenosis (AS) is subclassified into a true-severe (TS) and a pseudo-severe (PS) subform using low-dose dobutamine stress echocardiography (DSE). In clinical practice a resting peak jet velocity (Vmax) &gt;3.5 m/s or a mean transvalvular gradient&hellip;<span class="activity-read-more" id="activity-read-more-53029"><a href="https://recash.wpsoul.net/activity/p/53029/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">153f975a02f1a337d3d104237f95488b</guid>
				<title>Rasch Raun became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/52855/</link>
				<pubDate>Wed, 11 Dec 2024 17:14:38 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>